iiinova — where your digital self keeps evolving

Helen Rowe @RoweLab

@labrowe.bsky.social

955 followers 257 following 13 posts

Discovery science driven. Hope to contribute to translating discoveries into new medicines.

Posts Replies Media

Helen Rowe @RoweLab @labrowe.bsky.social · 28/09/2026

Fortuitous rendezvous lunch with some previous and current lab members, like a ray of light on a Friday afternoon! The best part of academia is the people you meet 😊

090

Helen Rowe @RoweLab @labrowe.bsky.social · 14/08/2026

* Hot off the press from the Rowe Lab 📢 * : For in depth insight on LINE-1 jumping genes, from their regulation to their multifaceted roles in cancer immunity, read Holly Jefferson's review here: www.mdpi.com/1999-4915/18...

052

Helen Rowe @RoweLab @labrowe.bsky.social · 16/06/2026

‪doi: doi.org/10.1038/s414... 📣 Our study is now out in Nature Communications detailing that the type I interferon pathway is suppressed by HUSH in early human development: Its complete epigenetic lockdown!! Incredible work from James Holt 📣 😎

0219

Helen Rowe @RoweLab @labrowe.bsky.social · 02/02/2024

I am honoured to receive a Programme Foundation Award from Cancer Research UK on epigenetic regulation of immune evasion in non-small cell lung cancer. Thanks to my co-investigators, collaborators, mentors, lab & @qmulepigenetics.bsky.social for supporting this exciting translational project.

2122

Helen Rowe @RoweLab @labrowe.bsky.social · 03/01/2024

Enlightening review from @KathleenHBurns lab: genesdev.cshlp.org/content/37/2...: LINE-1 activity and jumping contributes to genetic instability in cancer and understanding LINE-1 deregulation could lead to new therapeutic opportunities. A must-read.

012

Helen Rowe @RoweLab @labrowe.bsky.social · 30/12/2023

Elegant preprint identifying mutually exclusive targeting of HUSH1 vs. HUSH2 chromatin complexes for silencing dangerous LINE-1 elements in the human genome: www.biorxiv.org/content/10.1...

085